ArticleCancers2025

First-in-Human Phase II Clinical Trial of Multiplex IntraTumoral Immunotherapy (MITI) in Patients with Metastatic Solid Cancer (Abscopal 5001 Trial).

David G Bostwick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.